IGF2BP1 and colorectal carcinoma: We further found that LOC101928222 can interact with IGF2BP1 and enhance the stability of HMGCS2 mRNA in an m6A-dependent manner, thereby promoting cholesterol synthesis, and finally leading to the malignant CRC phenotype.